| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 4 gene promoter | 0.626 | 0.423 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1996 | 2017 | |||||||||
|
serotonin transporter intronic VNTR enhancer | 0.636 | 0.538 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2003 | 2015 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
group | 0.130 | None | 1.000 | 3 | 2 | 2006 | 2019 | |||||||||
|
Major affective disorder 4 | 0.780 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
Major affective disorder 6 | 0.780 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
P2RX5-TAX1BP3 readthrough (NMD candidate) | 0.588 | 0.769 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | |||||||||
|
Temple syndrome | 0.780 | 0.154 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
H3 histone pseudogene 19 | 0.631 | 0.577 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2006 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 1 | 2001 | 2004 | |||||||||
|
major affective disorder 1 | 0.743 | 0.269 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
major affective disorder 2 | 0.641 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | |||||||||
|
WASH complex subunit 1 | 0.780 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
group | 0.310 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
cat eye syndrome chromosome region | 0.599 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Adolescent idiopathic scoliosis | 0.593 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | |||||||||
|
immunoglobulin lambda variable 3-25 | 1.000 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin heavy constant gamma 1 (G1m marker) | 0.700 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 18a | 0.520 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
miR-17-92a-1 cluster host gene | 0.483 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |